Cargando…

Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]

Detalles Bibliográficos
Autores principales: Sinn, K., Mosleh, B., Steindl, A., Zoechbauer-Mueller, S., Dieckmann, K., Widder, J., Steiner, E., Klepetko, W., Hoetzenecker, K., Laszlo, V., Dome, B., Klikovits, T., Hoda, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198372/
https://www.ncbi.nlm.nih.gov/pubmed/35696745
http://dx.doi.org/10.1016/j.esmoop.2022.100523
_version_ 1784727599916777472
author Sinn, K.
Mosleh, B.
Steindl, A.
Zoechbauer-Mueller, S.
Dieckmann, K.
Widder, J.
Steiner, E.
Klepetko, W.
Hoetzenecker, K.
Laszlo, V.
Dome, B.
Klikovits, T.
Hoda, M.A.
author_facet Sinn, K.
Mosleh, B.
Steindl, A.
Zoechbauer-Mueller, S.
Dieckmann, K.
Widder, J.
Steiner, E.
Klepetko, W.
Hoetzenecker, K.
Laszlo, V.
Dome, B.
Klikovits, T.
Hoda, M.A.
author_sort Sinn, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9198372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91983722022-06-16 Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] Sinn, K. Mosleh, B. Steindl, A. Zoechbauer-Mueller, S. Dieckmann, K. Widder, J. Steiner, E. Klepetko, W. Hoetzenecker, K. Laszlo, V. Dome, B. Klikovits, T. Hoda, M.A. ESMO Open Corrigendum Elsevier 2022-06-10 /pmc/articles/PMC9198372/ /pubmed/35696745 http://dx.doi.org/10.1016/j.esmoop.2022.100523 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Sinn, K.
Mosleh, B.
Steindl, A.
Zoechbauer-Mueller, S.
Dieckmann, K.
Widder, J.
Steiner, E.
Klepetko, W.
Hoetzenecker, K.
Laszlo, V.
Dome, B.
Klikovits, T.
Hoda, M.A.
Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title_full Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title_fullStr Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title_full_unstemmed Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title_short Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
title_sort corrigendum to ‘neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage iii/n2 non-small-cell lung cancer: a retrospective single-center cohort study’: [esmo open volume 7, issue 2, april 2022, 100466]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198372/
https://www.ncbi.nlm.nih.gov/pubmed/35696745
http://dx.doi.org/10.1016/j.esmoop.2022.100523
work_keys_str_mv AT sinnk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT moslehb corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT steindla corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT zoechbauermuellers corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT dieckmannk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT widderj corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT steinere corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT klepetkow corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT hoetzeneckerk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT laszlov corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT domeb corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT klikovitst corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466
AT hodama corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466